CTAS vs SEPN · P/E 51, rev $11.26B vs rev $46.0M
Cintas Corporation (CTAS) versus Septerna, Inc. Common Stock (SEPN) — a side-by-side from cached financials, not a winner call.
Cintas Corporation (CTAS) is a specialty business services company listed on US.
Septerna, Inc. Common Stock (SEPN) is a biotechnology company listed on NASDAQ.
Latest reported CTAS revenue for 2026-05-31 was $11.26B. Net income was $2.00B. Revenue was up 8.9% from 2025-05-31 to 2026-05-31. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
Latest reported SEPN revenue for 2025-12-31 was $46.0M. Net income was -$48.9M. Revenue was up 4174.5% from 2024-12-31 to 2025-12-31. SEPN currently screens at market cap $1.61B.
CTAS currently screens at market cap $89.01B and trailing P/E 51.3. SEPN currently screens at market cap $1.61B.
Not investment advice. Open the CTAS and SEPN stock pages for the full models.
Not investment advice.